Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.6, 2002-06, pp. : 859-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuraminidase inhibitor RWJ 270201 prepares to compete in influenza market

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-09 ,pp. : 976-983

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir/peramivir: Development of oseltamivir and peramivir resistance in influenza A infection, in immunocompromised patients: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1309, 2010-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Neuraminidase Inhibitors in Pediatric Patients: Potential Place in Influenza Therapy

By Noyola D.E.

Pediatric Drugs, Vol. 5, Iss. 2, 2003-01 ,pp. : 125-131

Adis International

Access to resources Recommend Favorite

Potential New Targets for Antithrombotic Therapy

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. : 2367-2374

Bentham Science Publishers

Access to resources Recommend Favorite